
Astrazeneca Pharma India Ltd Falls to 52-Week Low of Rs 7,026 Amid Prolonged Downtrend
2026-08-31 09:49:53For the ninth consecutive session, Astrazeneca Pharma India Ltd has closed lower, slipping to a fresh 52-week low of Rs 7,026.55 on 31 Aug 2026, marking an 8.15% decline over this losing streak and underperforming its sector by nearly 1%. This persistent slide contrasts sharply with broader market movements and raises questions about the underlying causes and prospects for the stock.
Read full news article
Astrazeneca Pharma India Ltd Falls to 52-Week Low of Rs 7,085 Amid Prolonged Downtrend
2026-08-27 09:47:58For the seventh consecutive session, Astrazeneca Pharma India Ltd has closed lower, slipping to a fresh 52-week low of Rs 7,085.05 on 27 Aug 2026, marking a near 7% decline over this losing streak and underscoring persistent selling pressure despite a broadly mixed market backdrop.
Read full news article
Astrazeneca Pharma India Ltd Falls to 52-Week Low of Rs 7174 Amidst Prolonged Downtrend
2026-08-25 13:41:07For the fifth consecutive session, Astrazeneca Pharma India Ltd has closed lower, slipping to a fresh 52-week low of Rs 7,174.05 on 25 Aug 2026, marking a 6.05% decline over this period and underscoring persistent selling pressure despite the broader market's mixed performance.
Read full news article
Astrazeneca Pharma India Ltd is Rated Sell
2026-08-24 10:10:04Astrazeneca Pharma India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 02 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 24 August 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read full news article
Astrazeneca Pharma India Ltd Falls to 52-Week Low of Rs 7,450 as Sell-Off Deepens
2026-08-21 10:13:57For the third consecutive session, Astrazeneca Pharma India Ltd has seen its share price decline, culminating in a fresh 52-week low of Rs 7,450 on 21 Aug 2026. This marks a 24.3% drop from its 52-week high of Rs 9,850, underscoring persistent selling pressure despite a broadly stable market backdrop.
Read full news article
Astrazeneca Pharma India Ltd Falls to 52-Week Low of Rs 7,480 Amidst Profit Declines
2026-08-20 15:35:52Astrazeneca Pharma India Ltd has slipped to a fresh 52-week low of Rs 7,480.2 on 20 Aug 2026, extending a recent downtrend that has seen the stock underperform the broader market and its sector peers despite a backdrop of positive market momentum.
Read full news article
Astrazeneca Pharma India Ltd Falls to 52-Week Low of Rs 7,590 as Sell-Off Deepens
2026-08-19 10:41:11A sustained decline has pushed Astrazeneca Pharma India Ltd to a fresh 52-week low of Rs 7,590 on 19 Aug 2026, marking a notable underperformance against the broader market and its sector peers.
Read full news article
Astrazeneca Pharma India Ltd Falls to 52-Week Low of Rs 7,600 as Sell-Off Deepens
2026-08-18 10:45:52For the seventh consecutive session, Astrazeneca Pharma India Ltd has seen its share price decline, culminating in a fresh 52-week low of Rs 7,600 on 18 Aug 2026. This sustained downward momentum has dragged the stock down by nearly 7% over the past week, underperforming its sector and broader market indices.
Read full news article
Astrazeneca Pharma India Ltd Falls to 52-Week Low of Rs 7,624 Amidst Prolonged Downtrend
2026-08-17 10:19:35For the sixth consecutive session, Astrazeneca Pharma India Ltd has closed lower, slipping to a fresh 52-week low of Rs 7,624.4 on 17 Aug 2026, marking a 6.61% decline over this period amid broader market weakness.
Read full news articleAnnouncement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
25-Aug-2026 | Source : BSEPlease find the enclosed document of the Company in relation to the captioned subject for your reference.
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Disclosure Of ESG Rating
24-Aug-2026 | Source : BSEPlease find the enclosed intimation of the Company in relation to the captioned subject for reference.
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
21-Aug-2026 | Source : BSEPlease find the enclosed intimation of the Company in relation to the captioned subject for your reference.
Corporate Actions
No Upcoming Board Meetings
Astrazeneca Pharma India Ltd has declared 1800% dividend, ex-date: 31 Jul 26
Astrazeneca Pharma India Ltd has announced 2:10 stock split, ex-date: 15 Jun 06
No Bonus history available
No Rights history available






